BioXcel Therapeutics, Inc. BTAI

Set alert

Price alert · BTAI

All alert types
0.07 USD 0.00 0.00%

At close · Sep 4

1.30 +1.23 +1,659.13%

After hours · Sep 4, 4:00 PM ET

Bid
1.29 × 1
Ask
1.30 × 1
0.069 Day range 0.0935
0.30 52-week range 4.17
YTD
-95.38%
1 year
-96.36%
Open
0.091
Prev close
0.0739
Mkt cap
16.98M
Vol
47.48M
Avg vol
616.96K
EPS
-2.04
P/E
0.00
Div yield
0.00%
More statistics
Low
0.069
High
0.0935
Forward P/E
-0.21
Beta
0.29
Short ratio
0.93
Inst. own
8.76%
Dividend
0.00
Ex-div date
Earnings
Aug 6, 2024
50-d avg
0.53274
200-d avg
1.28
1y target
5.00

5D chart

Chart tools
Interval

Discussion (85)

Sign in to join the discussion

Member BTAI 1 year ago #1

$BTAI seems to have bottomed out, next resistance is 3.17 which it will surely reach.

Member BTAI 1 year ago #2

$BTAI seems to have consolidated in this area, we will see if it looks for MA200d

Member BTAI 1 year ago #6

$BTAI The Candlestick Patterns Hammer and Inverted Hammer both are bullish reversal patterns that indicate the end of a downtrend and the beginning of an uptrend. Hammer and Inverted Hammer candlestick patterns show that buyers are gaining strength, which could lead to an upward momentum. Below is a detailed explanation of each

Member BTAI 1 year ago #8

$BTAI Mizuho has raised its price target on BioXcel Therapeutics (NASDAQ:BTAI) to $4.00 from $2.00 while maintaining a Neutral rating following positive Phase 3 SERENITY At-Home study data for Igalmi/BXCL501. The stock, currently trading at $3.48, has shown significant volatility with a 42.5% gain over the past six months despite a challenging year-to-date performance.